Scientists at Washington University in St. Louis have created a biocompatible adhesive hydrogel that can stick to various surfaces underwater, with properties similar to natural mussel foot protein and spider silk. This breakthrough has potential applications in tissue repair, particularly for tendon-bone repair.
A new deep-learning algorithm, ECNet, has been developed to accelerate protein engineering by predicting the fitness of all possible sequences. By incorporating evolutionary history, ECNet outperforms current methods on several datasets and identifies novel mutants with improved fitness.
Stanford researchers have developed a mini CRISPR genome editing system that is smaller and more efficient than existing versions. The new system, called CasMINI, has been successfully tested in human cells and shows promise for treating various diseases, including eye disease, organ degeneration, and genetic diseases.
Researchers at Washington University in St. Louis have developed a method to produce synthetic muscle protein using microbes, which can be spun into fibers with exceptional toughness and strength. The resulting material has potential biomedical applications, such as sutures and tissue engineering.
Scientists have created a system dubbed "NanoporeTERs" allowing cells to express themselves in a whole new light. These new reporter proteins can detect multiple protein expression levels and shed new light on biological systems, enabling deeper analysis than before.
Recent advances in bioengineering and computational modeling have enabled researchers to study complex biological processes with molecular-level detail. Multidisciplinary work on proteins and modeling highlights challenges as the field develops high-resolution, high-throughput organs on a chip.
The article discusses protein engineering techniques used in synthetic biology, including rational design, de novo design, directed evolution, and combinatorial approaches. These methods have been widely adopted in the biomedical and biotechnological sectors, with recent patents obtained using engineered proteins.
Researchers at the University of Pittsburgh School of Medicine have engineered a protein called Ngb H64Q that reverses carbon monoxide poisoning in mice, reducing CO half-life from 320 minutes to 23 seconds.
A team of scientists engineered protein-shelled nanostructures called gas vesicles to exhibit properties useful for ultrasound technologies. The modified gas vesicles were shown to produce distinct signals, target specific cell types, and help create color ultrasound images.
Jin Kim Montclare, an associate professor at NYU Tandon School of Engineering, has been recognized as a rising star in chemical engineering. Her lab's research on engineered proteins has made breakthroughs in detoxifying organophosphates and developing environmentally responsive hydrogels.
Researchers at Berkeley Lab have successfully reengineered a building block of a geometric nanocompartment, allowing for the transfer of electrons and enabling new functionalities. The introduction of iron-sulfur clusters expands the potential of nanocompartments as custom-made chemical factories.
Researchers created novel, self-assembling nanoscale proteins capable of binding small molecules, resulting in fibers that crossed the diameter barrier to the microscale. This breakthrough advances tissue engineering and drug delivery, enabling potential applications for dual-purpose scaffolds and efficient drug delivery.
A new engineered protein from a reaper spider's venom may offer a promising candidate for therapeutic serums or vaccination against other venoms. The protein provides effective protection against the effects of pure spider venom in animal models.
David A. Estell, a Genencor researcher, received the Enzyme Engineering Award for his work on protein engineering and developing efficient proprietary technology for producing advanced biofuels. He has also initiated new technology development and holds over 70 issued U.S. patents.
A research team led by Professor Kam-bo Wong engineered thermophilic enzymes to increase their activity at high temperatures without compromising stability. The findings provide insights into the design of biotechnologically important enzymes.
Engineered proteins mimic titin, a key muscle protein, to create a tough yet extensible scaffold for muscle regeneration. The biodegradable biomaterial could aid in the healing process by allowing new tissue to grow across injuries.
James A. Wells, a UCSF professor and director of the small molecule discovery center, has made groundbreaking contributions to protein engineering and discovery. He integrates multiple disciplines to design molecules that selectively activate or inhibit cellular processes.
The method allows researchers to explore protein function and find new drug targets, with potential applications in gene therapy and agricultural genetic engineering. The 'control switch' provides precise control over protein activity levels.
A research team developed an engineered protein that effectively neutralizes Staphylococcus aureus toxin, preventing symptoms in rabbits and reversing illness after exposure. The protein has potential advantages over antibodies, including smaller size and faster clearance from the body.
Scientists create artificial mechanism of allosteric control based on mechanical tension, allowing for controlled switching of proteins in living cells. The breakthrough could lead to targeted pharmaceutical drugs with reduced side effects and improved understanding of protein molecular architecture.
Researchers have developed a technology to engineer proteins as widely adaptable bioelectronic sensors for detecting specific chemicals. The engineered proteins, when attached to electrodes, can produce an electric signal reflecting the chemical's identity and concentration.